BioSpace News Archive

Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the first patient has been dosed in DESTINY-Breast04, a global pivotal phase 3 study evaluating the safety and efficacy of [fam-] trastuzumab deruxtecan (DS-8201),

Adding another level of complexity, Sidney copes with post-traumatic stress disorder stemming from his deployment during Operation Enduring Freedom.

Ferring acquired exclusive U.S. commercialization rights for generic Ganirelix Acetate Injection for the prevention of premature ovulation in women undergoing fertility treatment

New Bio-Integrative Orthopedic Fixation Material Provides Unprecedented Combination of Mechanical Strength and Natural Bone Healing in a Non-Permanent Implant

FDA grants a Priority Review based on Phase 3 ATTR-ACT study findings in ATTR-CM

Youngevity International, Inc. (NASDAQ: YGYI), a leading omni-direct lifestyle company, announced today that it will be adding Icelandic Glacial™–The Purest Tasting Water on Earth–to its growing, multifaceted lineup of lifestyle brands in the health, wellness, and food and beverage industries by agreeing to an exclusive sales and marketing agreement with the brand.

Beyond Limits, a leading artificial intelligence engineering company, has announced the formation of a healthcare advisory board composed of prominent physicians and healthcare executives from world-renowned medical clinics and companies.

These enhancements complement the Pharma Edition PORTFOLIO™, a highly advanced clinical study budgeting and scenario modeling engine, with customers reporting greater than 95% forecast accuracy.

Accident survivors, medical professionals, and state policymakers share their perspectives on the value of this unique system.

Medical practitioners are optimistic about their practices’ finances but remain concerned about the impact of politics on the American healthcare industry, finds a survey released today by TD Bank, America’s Most Convenient Bank®.